Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Bernstein

Showing results (551-560 of 606) with videos related to

Pageof 61
Sort By:
The Journal of Allergy and Clinical Immunology. Global|July 12, 2026
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-STamar Kinaciyan, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, et al.
Allergy|October 10, 2023
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paperMarek Jutel, Ioana Agache, Magdalena Zemelka-Wiacek, et al.
Critical Care Medicine|March 7, 2020
Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care JournalsDaniel E Leisman, Michael O Harhay, David J Lederer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.
American Journal of Human Genetics|November 11, 2022
TCEAL1 loss-of-function results in an X-linked dominant neurodevelopmental syndrome and drives the neurological disease trait in Xq22.2 deletionsHadia Hijazi, Linda M Reis, Davut Pehlivan, et al.
American Journal of Human Genetics|September 26, 2017
Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic FeaturesPaweł Stankiewicz, Tahir N Khan, Przemyslaw Szafranski, et al.
The Journal of Allergy and Clinical Immunology|May 31, 2015
Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseasesDirk Holzinger, Selina Kathleen Fassl, Wilco de Jager, et al.
The World Allergy Organization Journal|June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trialsEmel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
The New England Journal of Medicine|October 11, 2018
Effect of Genetic Diagnosis on Patients with Previously Undiagnosed DiseaseKimberly Splinter, David R Adams, Carlos A Bacino, et al.
Clinical and Translational Allergy|January 28, 2024
CRUSE<sup>®</sup> -An innovative mobile application for patient monitoring and management in chronic spontaneous urticariaSophia Neisinger, Bernardo Sousa Pinto, Aiste Ramanauskaite, et al.
Pageof 61

Showing results (551-560 of 606) with videos related to

Sort By:
Pageof 61
The Journal of Allergy and Clinical Immunology. Global|July 12, 2026
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-STamar Kinaciyan, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, et al.
Allergy|October 10, 2023
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paperMarek Jutel, Ioana Agache, Magdalena Zemelka-Wiacek, et al.
Critical Care Medicine|March 7, 2020
Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care JournalsDaniel E Leisman, Michael O Harhay, David J Lederer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.
American Journal of Human Genetics|November 11, 2022
TCEAL1 loss-of-function results in an X-linked dominant neurodevelopmental syndrome and drives the neurological disease trait in Xq22.2 deletionsHadia Hijazi, Linda M Reis, Davut Pehlivan, et al.
American Journal of Human Genetics|September 26, 2017
Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic FeaturesPaweł Stankiewicz, Tahir N Khan, Przemyslaw Szafranski, et al.
The Journal of Allergy and Clinical Immunology|May 31, 2015
Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseasesDirk Holzinger, Selina Kathleen Fassl, Wilco de Jager, et al.
The World Allergy Organization Journal|June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trialsEmel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
The New England Journal of Medicine|October 11, 2018
Effect of Genetic Diagnosis on Patients with Previously Undiagnosed DiseaseKimberly Splinter, David R Adams, Carlos A Bacino, et al.
Clinical and Translational Allergy|January 28, 2024
CRUSE<sup>®</sup> -An innovative mobile application for patient monitoring and management in chronic spontaneous urticariaSophia Neisinger, Bernardo Sousa Pinto, Aiste Ramanauskaite, et al.
Pageof 61